FGFR1 and PROKR2 rare variants found in patients with combined pituitary hormone deficiencies

The genetic aetiology of congenital hypopituitarism (CH) is not entirely elucidated. FGFR1 and PROKR2 loss-of-function mutations are classically involved in hypogonadotrophic hypogonadism (HH), however, due to the clinical and genetic overlap of HH and CH; these genes may also be involved in the pathogenesis of CH. Using a candidate gene approach, we screened 156 Brazilian patients with combined pituitary hormone deficiencies (CPHD) for loss-of-function mutations in FGFR1 and PROKR2. We identified three FGFR1 variants (p.Arg448Trp, p.Ser107Leu and p.Pro772Ser) in four unrelated patients (two males) and two PROKR2 variants (p. Arg85Cys and p. Arg248Glu) in two unrelated female patients. Five of the six patients harbouring the variants had a first-degree relative that was an unaffected carrier of it. Results of functional studies indicated that the new FGFR1 variant p.Arg448Trp is a loss-of-function variant, while p.Ser107Leu and p.Pro772Ser present signalling activity similar to the wild-type form. Regarding PROKR2 variants, results from previous functional studies indicated that p.Arg85Cys moderately compromises receptor signalling through both MAPK and Ca2+ pathways while p.Arg248Glu decreases calcium mobilization but has normal MAPK activity. The presence of loss-of-function variants of FGFR1 and PROKR2 in our patients with CPHD is indicative of an adjuvant and/or modifier effect of these rare variants on the phenotype. The presence of the same variants in unaffected relatives implies that they cannot solely cause the phenotype. Other associated genetic and/or environmental modifiers may play a role in the aetiology of this condition.

Palavras-chave

combined pituitary hormone deficiencies, FGFR1, PROKR2, hypopituitarism

URI

https://observatorio.fm.usp.br/handle/OPI/17013

Referências

Abreu AP, 2012, MOL ENDOCRINOL, V26, P1417, DOI 10.1210/me.2012-1102
Abreu AP, 2008, J CLIN ENDOCR METAB, V93, P4113, DOI 10.1210/jc.2008-0958
Asakura Yumi, 2015, Clin Pediatr Endocrinol, V24, P27, DOI 10.1297/cpe.24.27
Cole LW, 2008, J CLIN ENDOCR METAB, V93, P3551, DOI 10.1210/jc.2007-2654
Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012
Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122
Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175
Fukami M, 2013, ENDOCR J, V60, P1013
Izumi Y, 2014, FERTIL STERIL, V102, P1130, DOI 10.1016/j.fertnstert.2014.06.017
Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008
Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200
Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103
McCabe MJ, 2013, J CLIN ENDOCR METAB, V98, pE547, DOI 10.1210/jc.2012-3067
McCabe MJ, 2011, J CLIN ENDOCR METAB, V96, pE1709, DOI 10.1210/jc.2011-0454
Mehta A, 2009, CLIN ENDOCRINOL, V71, P376, DOI 10.1111/j.1365-2265.2009.03572.x
Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318
Osorio MGF, 2002, J CLIN ENDOCR METAB, V87, P5076, DOI 10.1210/jc.2001-011936
Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104
Raivio T, 2009, J CLIN ENDOCR METAB, V94, P4380, DOI 10.1210/jc.2009-0179
Raivio T, 2012, J CLIN ENDOCR METAB, V97, pE694, DOI 10.1210/jc.2011-2938
Reynaud R, 2012, J CLIN ENDOCR METAB, V97, pE1068, DOI 10.1210/jc.2011-3056
Streit A, 2007, INT J DEV BIOL, V51, P447, DOI 10.1387/ijdb.072327as
Sykiotis GP, 2010, P NATL ACAD SCI USA, V107, P15140, DOI 10.1073/pnas.1009622107
TANNER JM, 1966, ARCH DIS CHILD, V41, P613
Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X
Trarbach EB, 2006, J CLIN ENDOCR METAB, V91, P4006, DOI 10.1210/jc.2005-2793
Vermeulen S, 2002, AM J MED GENET, V108, P315, DOI 10.1002/ajmg.10295

Coleções

Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/25
Artigos e Materiais de Revistas Científicas - LIM/42

Página do item completo